Triangle-based NightHawk (formerly Heat Bio) changes focus; CEO to lead biodefense spin-off
Morrisville-based NightHawk Biosciences is changing direction – and business strategy. Here’s what the changes mean.
Read More
heat biologics
NightHawk subsidiary Scorpion has new interim CEO and plans to build new facility in Kansas
NightHawk Biosciences has appointed a new interim CEO for its subsidiary company Scorpion Biological Services, which is expanding into Kansas.
Read More
Morrisville life science firm Heat Biologics is changing name to NightHawk Biosciences
Heat Biologics has hit upon a new name that it says is a better reflection of its recent growth and evolution as a company.
Read More
Targeting anthrax: Durham firm aims to be global biodefense leader with latest deal
A biodefense company which already has an anti-anthrax product and has secured more than $350 million in federal contracts will soon become part of Durham-based Heat Biologics under terms of a deal announced before markets opened Tuesday.
Read More
Skunkworx: That’s new rapid drug development firm spinning off from Morrisville’s Heat Bio
Morrisville-based biopharmaceutical company Heat Biologics will spin off a new company, Skunkworx, focusing on rapid drug discovery.
Read More
Morrisville’s Heat Biologics to double its R&D center, grow to 15,000+ sqft
According to the North Carolina Biotechnology Center, Heat Biologics will double the size of its research and development center in Morrisville, increasing to about 15,000 square feet of lab and office space.
Read More
Lung cancer treatment from Heat Bio continues to show promise in clinical trial
The clinical-stage biopharmaceutical company reported positive interim results from a phase 2 clinical trial of its therapy to treat advanced non-small cell lung cancer
Read More
Triangle biotech moves closer to human testing for COVID-19 vaccine
Heat Biologics, a clinical-stage immunotherapies developer, is moving closer to human testing of a vaccine for COVID-19. Here’s an update.
Read More
A top executive at Heat Biologics is stepping down
Heat Biologics, Inc., an immunotherapy-focused biotechnology company, announced on Sunday that its chief scientific and operating officer, Jeff T. Hutchins, Ph.D., will be leaving the company at the end of the year.
Read More
